Biotron Limited Stock Performance

BITRF Stock  USD 0  0.00  0.00%   
Biotron holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.9, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Biotron are expected to decrease by larger amounts. On the other hand, during market turmoil, Biotron is expected to outperform it. Use Biotron variance, skewness, as well as the relationship between the Skewness and day typical price , to analyze future returns on Biotron.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotron Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Biotron reported solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Biotron Relative Risk vs. Return Landscape

If you would invest  1.30  in Biotron Limited on November 12, 2025 and sell it today you would lose (1.00) from holding Biotron Limited or give up 76.92% of portfolio value over 90 days. Biotron Limited is currently producing 12.7151% returns and takes up 128.4115% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Biotron, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Biotron is expected to generate 158.55 times more return on investment than the market. However, the company is 158.55 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Biotron Target Price Odds to finish over Current Price

The tendency of Biotron Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0 90 days 0 
about 66.01
Based on a normal probability distribution, the odds of Biotron to move above the current price in 90 days from now is about 66.01 (This Biotron Limited probability density function shows the probability of Biotron Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Biotron Limited has a beta of -1.9 suggesting as returns on its benchmark rise, returns on holding Biotron Limited are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Biotron is expected to outperform its benchmark. In addition to that Biotron Limited has an alpha of 22.5823, implying that it can generate a 22.58 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Biotron Price Density   
       Price  

Predictive Modules for Biotron

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotron Limited. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.00050.15
Details
Intrinsic
Valuation
LowRealHigh
0.00050.15
Details

Biotron Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotron is not an exception. The market had few large corrections towards the Biotron's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotron Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotron within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
22.58
β
Beta against Dow Jones-1.9
σ
Overall volatility
0.01
Ir
Information ratio 0.11

Biotron Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotron for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotron Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Biotron Limited is way too risky over 90 days horizon
Biotron Limited has some characteristics of a very speculative penny stock
Biotron Limited appears to be risky and price may revert if volatility continues
The company reported the revenue of 1.56 M. Net Loss for the year was (2.78 M) with profit before overhead, payroll, taxes, and interest of 1.56 M.
Biotron Limited has accumulated about 1.74 M in cash with (2.44 M) of positive cash flow from operations.
Roughly 14.0% of the company shares are held by company insiders

Biotron Fundamentals Growth

Biotron Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Biotron, and Biotron fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotron Pink Sheet performance.

About Biotron Performance

By analyzing Biotron's fundamental ratios, stakeholders can gain valuable insights into Biotron's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biotron has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotron has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Things to note about Biotron Limited performance evaluation

Checking the ongoing alerts about Biotron for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Biotron Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Biotron Limited is way too risky over 90 days horizon
Biotron Limited has some characteristics of a very speculative penny stock
Biotron Limited appears to be risky and price may revert if volatility continues
The company reported the revenue of 1.56 M. Net Loss for the year was (2.78 M) with profit before overhead, payroll, taxes, and interest of 1.56 M.
Biotron Limited has accumulated about 1.74 M in cash with (2.44 M) of positive cash flow from operations.
Roughly 14.0% of the company shares are held by company insiders
Evaluating Biotron's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Biotron's pink sheet performance include:
  • Analyzing Biotron's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotron's stock is overvalued or undervalued compared to its peers.
  • Examining Biotron's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Biotron's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotron's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Biotron's pink sheet. These opinions can provide insight into Biotron's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Biotron's pink sheet performance is not an exact science, and many factors can impact Biotron's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Biotron Pink Sheet analysis

When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets